IP Verse

Use Of Myostatin Inhibitors And Combination Therapies

Patent No. EP3368069 (titled "Use Of Myostatin Inhibitors And Combination Therapies") was filed by Scholar Rock on Jun 13, 2017. The application was issued on Aug 5, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GRUNDMay 4, 2021POHLMAN
HOFFMANN EITLEApr 28, 2021HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3368069

SCHOLAR ROCK
Application Number
EP17732001A
Filing Date
Jun 13, 2017
Status
Granted And Under Opposition
Jul 3, 2020
Publication Date
Aug 5, 2020
External Links
Slate, Register , Google Patents